Ontera Expands Leadership Team with Accomplished Diagnostic Industry Executives
Summary
Previously, he held various sales leadership roles at Beckman Coulter, Leica Biosystems, Siemens, and Ventana Medical Systems (Roche Tissue Diagnostics). “I am extremely impressed by the novel technology employed by the NanoDetector, which is Ontera’s first planned commercial point-of-care device, and I am excited about the significant future potential that the company’s platform holds for democratizing patient access to important health data,” said Mr. Marr. “I am thrilled to be a part of the world-class leadership team that Ontera has assembled and look forward to contributing to the company’s future commercial success.” John J. Sperzel is the President and CEO of T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens. Previously, Mr. Sperzel served as President and CEO of ITC Medical (Werfen), and he held executive leadership positions at Axis-Shield (Abbott), Bayer Diagnostics (Siemens), Instrumentation Laboratory, and Boehringer Mannheim (Roche). “I look forward to working with the Board and leadership team to bring this novel platform to customers around the world.” Ontera was founded with the idea that better information is needed to enhance human and environmental health in a sustainable way.